Lv1
38 积分 2022-09-30 加入
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
7个月前
已完结
Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment
8个月前
已完结
皖公网安备34019202002308